Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
Katherine E WarrenGilbert VezinaMark KrailoLinda SpringerAllen BuxtonCody J PeerWilliam Douglas FiggChris William-HughesSandy KesselMaryam FouladiAmar J GajjarDaniel C BowersPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
/dose administered once daily × 21 days of each 28-day cycle) lenalidomide appears to have better tolerability with comparable activity.